Related Experiment Video
Updated: Jul 20, 2026
15:43
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Anaerobic Infections of the Lung
1Infectious Diseases Section, Department of Medicine, VA Greater Los Angeles Healthcare System (111-F), 11301 Wilshire Boulevard, Los Angeles, CA 90073, USA. matthew.goetz@med.va.gov
Current Infectious Disease Reports
|November 30, 2000
Summary
Anaerobic bacteria cause serious lung infections, but their exact incidence in hospitalized patients is debated. Changing antibiotic resistance necessitates updated treatment strategies beyond penicillin alone.
Area of Science:
- Infectious Diseases
- Pulmonology
- Microbiology
Background:
- Anaerobic pathogens are significant causes of pleuropulmonary infections, contributing to morbidity and mortality.
- Despite advances, the incidence of anaerobic pulmonary infections, particularly in hospitalized individuals, remains a subject of debate.
- The evolving antimicrobial susceptibility of oral anaerobes challenges traditional treatment protocols.
Purpose of the Study:
- To review the pathogenesis of anaerobic pulmonary infections.
- To discuss the clinical presentations of these infections.
- To examine current management strategies and challenges.
Main Methods:
- Literature review of anaerobic pulmonary infections.
- Analysis of clinical data and diagnostic methods.
- Evaluation of antimicrobial susceptibility trends.
Main Results:
- Anaerobic pleuropulmonary infections continue to be a critical health concern.
- Diagnostic challenges and controversial incidence rates persist.
- Penicillin monotherapy is no longer sufficient for severe cases due to resistance.
Conclusions:
- Understanding anaerobic pathogen behavior is crucial for effective treatment.
- Updated diagnostic and therapeutic approaches are essential.
- Management must adapt to changing antimicrobial resistance patterns.
Related Concept Videos
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:29Microbiota of the Respiratory Tract
The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...